Form 4 for MRNA Moderna
Accepted 2025-02-14 00:00:00 ET · period of report 2025-02-12 · accession 0001127602-25-004871 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-14 | 2025-02-12 | MRNA | Bancel Stephane | CEO, Dir | F - Tax | $30.93 | -6,400 | 5.49M | -0.1% | -$198.0K | |
| 2025-02-14 | 2025-02-12 | MRNA | Bancel Stephane | CEO, Dir | A - Grant | $0.00 | +13.2K | 5.50M | +0.2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-12 | F | D | 6,400 | $30.93 | 5,493,897 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-12 | A | A | 13,233 | $0.00 | 5,500,297 | D | — | — |